podcast

Market Access

The value of a partner, globally and locally

A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face

Patients

pharmaphorum podcast Episode 177a - Rob Abbott, ISPOR

The ins and outs of HEOR – A lever for global health

Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.

Market Access

Man listening to podcast featuring Alice Valder Curran

Unpacking Trump’s executive order on drug pricing, with Alic...

Jonah Comstock welcomed back Alice Valder Curran to the podcast to pick apart Trump's Executive Order order piece by piece.

Digital

pharmaphorum podcast Episode 176a - Andrew Stelzer, Unlearn.AI

AI in drug development: The real hurdle is implementation

Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.

Digital

pharmaphorum podcast Episode 175a - Bill Grambley, AllazoHealth

Patients as active consumers of care: AI-driven personalisat...

In a new podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing.

R&D

pharmaphorum podcast Episode 174a - Tomasz Kostrzewski, CN Bio

Driving the drug discovery pipeline: The value of organ-on-a...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.